Home / 2012 (page 85)

Yearly Archives: 2012

Avandia, Actos May Raise Risk of Macular Edema

Pioglitazone (Actos) and rosiglitazone (Avandia) appear to substantially boost risk of macular edema in type 2 diabetes, an observational study found. Incidence of diabetic macular edema was 1.3% at 1 year on a thiazolidinedione (TZD) compared with just 0.2% among type 2 diabetes patients not on one of those agents. …

Read More »

Fish Oil Fails to Reduce CV Event Risk

Omega-3 fatty acids did not reduce the rate of cardiovascular events in high-risk patients with prediabetes or diabetes followed for half a dozen years, the randomized ORIGIN trial found. Cardiovascular deaths occurred among 9.1% and 9.3% of those randomized to n-3 fatty acids or placebo, respectively. N Engl J Med 2012 

Read More »

Statins Sap Energy

Statin drugs may leave users — especially women — feeling drained and tired on exertion, a clinical trial suggested. Combined scores for change in energy and exertional fatigue worsened after starting a statin compared with placebo (P=0.005). For women, scores suggested that as many as 40% felt more tired and …

Read More »